Browse drugs

…erval (33.3%) and to restart the drug (25.0%). In patients with ustekinumab, the main interventions were to shorten the dosing interval (55…

… patient restarted oral posaconazole and one patient changed to micafungin.From those patients who switched PAP to IV micafungin 3-4 mg/kg…

…arbital remains the first-line therapy in our NICU, followed by levetiracetam. Lidocaine has proven to be an effective and safe third-line th…

… metronidazole (+415.26%), ampicillin/sulbactam (+367.20%), and amikacin (+177.96%), while lowest consumption was observed for oxacillin…

…nalysis of the phase 3 PHILA trial confirmed the superiority of pyrotinib in combination with trastuzumab and docetaxel over placebo in c…

… Due to therapeutic failure with rituximab, she was switched to anifrolumab. Twelve days after the first infusion, she developed a painful …

…cations affecting liver metabolism or lipid metabolism, such as statins, fibrates, or corticosteroids within the past 3 months.Sample s…

…ased economic burden.2–4 Every 10% increase in non-adherence to metformin and statins is associated with a 0.14% increase in hemoglobin A…

…mised, 2/102 (2.0%) in the gentamicin arm, 49/97 (50.5%) in the ertapenem arm, 32/37 (86.5%) in the fosfomycin arm and 11/103 (10.7%) in …

…a vs glatiramer acetate), RIFUND-MS (rituximab vs DMF), TENERE (teriflunomide vs interferon beta) and TRANSFORMS (fingolimod vs interferon be…

…ating therapy with LABA-ICS inhalers may be more effective than LABA-LAMA inhalers among patients with multiple exacerbations, particular…

… on peripheral T cell stemness in mice and humans. We show that PDS01ADC treatment in patients with advanced solid tumors boosts periphe…